.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Abstract talk
O 108

NRF2 activators inhibit hepatitis E virus propagation in vitro

Appointment

Date: 28/03/2024

Time: 11:30 – 11:45

Talk time: 12 Min.

Discussion time: 3 Min.

Location / Stream:

Lecture hall 3

Session

Antiviral therapy and resistance 2

Topic

Antiviral therapy and resistance

Authors

Fenja Laue (Hannover / DE), Vira Matulapelwa (Hannover / DE), Dr. Fakhar Waqas (Hannover / DE), Lucas Hüffner (Hannover / DE), Mara Klöhn (Bochum / DE), Dr. Florian Hinte (Hamburg / DE), Xin Zhang (Leuven / BE), Suzanne J.F. Kaptein (Leuven / BE), Johan Neyts (Leuven / BE), Professor Maura Dandri (Hamburg / DE), Professor Frank Pessler (Hannover / DE), Professor Thomas Pietschmann (Hannover / DE; Braunschweig / DE), Dr. Patrick Behrendt (Hannover / DE; Braunschweig / DE)